Pilot clinical study of T-Guard in critically ill patients with graft-versus-host disease
Latest Information Update: 17 Jan 2014
Price :
$35 *
At a glance
- Drugs Anti-CD3-ricin chain A conjugate/anti-CD7-ricin chain A conjugate (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- 17 Jan 2014 New trial record